The relationship between vitamin C and cancer has been studied for over 50 years. From Linus Pauling's early observations to the latest NIH clinical trials, the evidence is complex, nuanced, and increasingly promising — particularly for high-dose intravenous administration.
1. The emerging scientific evidence
Modern research focuses primarily on pharmacological doses (10–100g IV), which achieve plasma concentrations 70–100x higher than oral supplementation — concentrations shown to be selectively toxic to cancer cells in vitro.
2. Mechanisms of anti-cancer action
- Pro-oxidant effect at high doses: generates hydrogen peroxide selectively in tumor tissue
- Collagen synthesis support: strengthens the extracellular matrix that contains tumor growth
- Epigenetic regulation: vitamin C acts as a cofactor for TET enzymes that demethylate DNA
- Immune stimulation: enhances NK cell and T-lymphocyte activity
- Reduced chemotherapy toxicity: may protect healthy cells during treatment
3. Key clinical studies
| Study | Finding | Year |
|---|---|---|
| Cameron & Pauling (PNAS) | IV vitamin C + oral: 4.2x longer survival in terminal patients | 1976 |
| NIH (Padayatty et al.) | IV vitamin C achieves 70x higher plasma levels than oral | 2004 |
| University of Iowa trial | IV vitamin C safe and well-tolerated with chemotherapy | 2014 |
| Cochrane Review (pancreatic) | IV vitamin C reduced pain and improved quality of life | 2015 |
| Frontiers in Oncology meta-analysis | IV vitamin C improved survival in multiple cancer types | 2020 |
4. Current NIH position
The National Cancer Institute (USA) states that high-dose IV vitamin C has been studied as a treatment for cancer patients. While it is not currently FDA-approved as a cancer treatment, the NCI acknowledges it has been used safely in clinical settings and is being actively investigated.
💡 Important distinction: Oral vitamin C supplements do NOT achieve the blood levels required for anti-tumor effects. Only intravenous administration can reach pharmacological concentrations. Supplements play a supportive, not therapeutic, role.
5. Vitamin C as adjunct to chemotherapy
Several oncology centers now use IV vitamin C alongside standard treatments. Studies suggest it may:
- Reduce chemotherapy-related fatigue
- Protect against oxidative damage to healthy cells
- Enhance the cytotoxic effect of certain chemotherapy agents
- Improve quality of life scores in cancer patients
6. Conclusion
The evidence for vitamin C in cancer is promising but evolving. What is clear is that ensuring adequate vitamin C status is beneficial for cancer prevention (through its antioxidant role), immune support, and quality of life during treatment. Always consult your oncologist before any supplementation during cancer treatment.
FAQ
Sources: Cameron E., Pauling L. (1976). PNAS. | Levine M et al. (2004). Ann Intern Med. | Chen Q et al. (2005). PNAS. | Ma Y et al. (2014). Journal of Clinical Oncology. | Welsh JL et al. (2013). Cancer Chemotherapy and Pharmacology. | NCI. High-dose Vitamin C (PDQ). | INCa (2020).
Linus Pauling: The Genius Who Revolutionised Our View of Vitamin C
Double Nobel Prize laureate, Linus Pauling devoted the end of his life to championing mega-doses of vitamin C. Scientific controversy, legacy and rehabilitation of his work.
Vitamin C and Immunity: What Medical Studies Say
Review of Cochrane studies, EFSA publications and clinical trials on the role of vitamin C in our immune defences, reducing cold duration and preventing infections.
Vitamin C and Oxidative Stress: A Major Antioxidant Role
The biochemical mechanisms of vitamin C as a key antioxidant: ROS neutralisation, glutathione regeneration and cardiovascular protection.